AzTrials
AzTrials

Multiple Rib FracturesPhase 4NCT06958549

Role of Nerve Block in Management of Multiple Rib Fractures

A Phase 4 study testing Nerve block with Lidocain and pharmacological analgesics in people with Multiple Rib Fractures, run by Assiut University.

Not yet recruiting

Opening soon. The study is approved but enrolment has not started yet. Sites may already take enquiries.

Sites and contacts
Official record
Search all trials

Trial summary

Epidemiology \& Impact Thoracic trauma is a common and serious injury worldwide-especially in developing countries-and carries high rates of morbidity and mortality. Complications arise primarily from hypoventilation, which leads to atelectasis, pneumonia, and respiratory failure. Read more about this study

Who is it for?
Ages 18 to 70 years
Conditions the study is for
Multiple Rib Fractures
What is being tested?
Nerve block with Lidocain and pharmacological analgesics
Could I receive a placebo?
No, everyone receives an active treatment
How many people
74 participants
Where
No sites listed yet
Study dates
Dec 2025to Apr 2027
Phase
Phase 4
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 70 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • All trauma adult patient (18-70 years) with multiple fracture ribs

Who cannot join

  • Patient with multiple fracture rib with anterior flail segment
  • Significant head trauma

Trial locations and contacts

No sites are listed yet. Contact the study team or a site near you to ask about taking part.

About this study

Official title: Management of Multiple Rib Fractures; Role of Nerve Block

  • Epidemiology \& Impact Thoracic trauma is a common and serious injury worldwide-especially in developing countries-and carries high rates of morbidity and mortality. Complications arise primarily from hypoventilation, which leads to atelectasis, pneumonia, and respiratory failure.
  • Key to Reducing Complications: Pain Control Effective analgesia is the cornerstone of preventing respiratory complications. Inadequate pain relief causes patients to splint and hypoventilate, setting the stage for pulmonary collapse and infection.
  • Conservative Management
  • Analgesics: Systemic pharmacological pain relief remains the mainstay.
  • Supportive Measures: Rest, application of ice, and encouragement of deep breathing exercises.
  • Incentive Spirometry: Promoted in all patients to maintain lung expansion and ward off atelectasis.
  • Regional Anesthesia Techniques

To further improve comfort and respiratory mechanics, ultrasound-guided nerve blocks are employed according to fracture location:

  • Serratus Anterior Plane Block for anterolateral rib fractures
  • Thoracic Paravertebral Block for posterior rib fractures
  • Surgical Intervention Reserved for complex cases-such as flail chest or fractures with risk of organ injury-where stabilization or repair may be necessary.
  • Identified Gap Despite these options, thoracic surgeons currently lack a standardized, procedure-specific pain management protocol beyond systemic analgesics, highlighting a need for consensus guidelines that integrate pharmacological and regional techniques.
Read the detailed description

Thoracic trauma is a major traumatic injury throughout the world, and it has very high incidence in developing countries. Thoracic trauma is often associated with significant morbidity and mortality. Morbidity is due to atelectasis, pneumonia, and respiratory failure as a sequence of hypoventilation.

Most important factor in preventing complications in these patients is pain management. There are different lines of management of multiple rib fractures; conservative therapy is a common line of management which includes appropriate analgesic, rest, and ice.

The use of an incentive spirometer should be encouraged to prevent pulmonary atelectasis and splinting.

Nerve block can also be applied to aid in pain control, surgery may also be a line of management for complicated cases.

The type of nerve block differs according to the site of the fracture; Ultrasound-Guided Serratus Anterior Plane Block is often used for anterolateral rib fractures and Ultrasound-Guided Thoracic Paravertebral Block is used for posterior rib fractures.

The problem here is that ; There is no pain management protocol to be done by thoracic surgeons other than pharmacological analgesics.

This randomized prospective study will be performed in Assiut University Hospitals on two groups of trauma patients, each group is 37 patients; one will undergo nerve block by injection of Lidocaine (7mg/kg) with Epinephrine 1:100000 under ultrasonographical guidance and the other will receive pharmacological analgesics (Oral Paracetamol (500mg/6hr), IV Ketolac (15mg/6hr) and IV perfelgan (1gm/6hr)).

Then improvement in patients pain score, intercostal tube duration in days and total hospital stay in days, patient satisfaction using questionnaire will be assessed.

Being tested
Nerve block with Lidocain, pharmacological analgesics

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Nerve block with LidocainProcedure or surgery

    Injection of Lidocaine (7mg/kg) with Epinephrine 1:100000 under Ultrasonographical guidance

  • pharmacological analgesicsDrug

    Oral Paracetamol (500mg/6hr), IV Ketolac (15mg/6hr) and IV perfelgan (1gm/6hr)

Study groups in NCT06958549
Study groupRoleWhat they receive
nerve blockActive comparatorNot described
Receives: Procedure: Nerve block with Lidocain
pharmacological analgesicsActive comparatorNot described
Receives: Drug: pharmacological analgesics

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Improvement in patients pain score (neumerical score)

    Measured: day 0, day 1 and day 3

Secondary outcomes (3)
  1. improving intercostal tube duration in days

    Measured: day 2, day 4 and day 6

  2. improving total hospital stay in days

    Measured: day 2, day 4 and day 6

  3. improving patient satisfaction (questionnaire)

    Measured: day 0, day 2, day 4 and day 6

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted6 May 2025
  2. Study startDec 2025 (estimated)
  3. Primary completionDec 2026 (estimated)
  4. Study completionApr 2027 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase 4
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
74 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06958549
Sponsor's protocol ID
RIBFRACTURE
Status last verified
Apr 2025
First submitted
16 Apr 2025
Last updated
6 May 2025
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided

Publications

  • Kring RM, Mackenzie DC, Wilson CN, Rappold JF, Strout TD, Croft PE. Ultrasound-Guided Serratus Anterior Plane Block (SAPB) Improves Pain Control in Patients With Rib Fractures. J Ultrasound Med. 2022 Nov;41(11):2695-2701. doi: 10.1002/jum.15953. Epub 2022 Feb 2.

    PubMed 35106815
  • Yayik AM, Aydin ME, Tekin E, Ulas AB, Ahiskalioglu A. An alternative plane block for multiple rib fractures: Rhomboid Intercostal and Sub-Serratus block (RISS). Am J Emerg Med. 2019 Dec;37(12):2263.e5-2263.e7. doi: 10.1016/j.ajem.2019.158429. Epub 2019 Sep 6.

    PubMed 31526541
  • Hwang EG, Lee Y. Effectiveness of intercostal nerve block for management of pain in rib fracture patients. J Exerc Rehabil. 2014 Aug 31;10(4):241-4. doi: 10.12965/jer.140137. eCollection 2014 Aug.

    PubMed 25210700
  • Easter A. Management of patients with multiple rib fractures. Am J Crit Care. 2001 Sep;10(5):320-7; quiz 328-9.

    PubMed 11548565

Questions about this trial

What is this clinical trial studying?

A Phase 4 study testing Nerve block with Lidocain and pharmacological analgesics in people with Multiple Rib Fractures, run by Assiut University.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: opening soon, as of the sponsor's last update on 6 May 2025. Status can change between updates, so confirm with the study contact before making plans.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

What does this phase mean?

Phase 4 studies take place after a treatment is approved, to learn more about its long-term benefits and risks in everyday use.

Not every study follows the same path, and some studies (observational studies, device studies) have no phase.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Mostafa A Kotb (+201091703324, Moustafa.16266040@med.aun.edu.eg), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Improvement in patients pain score (neumerical score) (time frame: day 0, day 1 and day 3). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT06958549, which also lists 4 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 6 May 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in